West Pharmaceutical Services
WST · New York Stock Exchange · Health Care
☆ Follow
Shareholder advocacy aimed at West Pharmaceutical Services
Nothing recorded yet. That means no campaign in our database names this company, not that none exists.
What shareholders voted on
From West Pharmaceutical Services’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.
2026
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal regarding an Independent Board Chair Policy | Shareholder proposal | 46.4% | Failed | |
| Approve the compensation of the Company’s named executive officers | Say on pay | 94.1% | Passed | |
| The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year | Auditor | 88.6% | Passed | |
| Election of Stephen H. Lockhart | Director | 99.3% | Passed | |
| Election of Paolo Pucci | Director | 98.5% | Passed | |
| Election of Robert F. Friel | Director | 97.6% | Passed | |
| Election of Mark A. Buthman | Director | 97.6% | Passed | |
| Election of Janet B. Haugen | Director | 96.9% | Passed | |
| Election of Myla P. Lai-Goldman | Director | 96.3% | Passed | |
| Election of Molly E. Joseph | Director | 96.3% | Passed | |
| Election of William F. Feehery | Director | 96.1% | Passed | |
| Election of Douglas A. Michels | Director | 94.3% | Passed | |
| Election of Eric M. Green | Director | 92.8% | Passed | |
| Election of Deborah L. V. Keller | Director | 91.2% | Passed |
2025
2024
2023
2022
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote | Company proposal | 93.2% | Passed | |
| Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2022 fiscal year by the following vote | Auditor | 91.2% | Passed | |
| Election of Molly E. Joseph | Director | 99.7% | Passed | |
| Election of Paolo Pucci | Director | 99.4% | Passed | |
| Election of Myla P. Lai-Goldman | Director | 99.4% | Passed | |
| Election of Robert F. Friel | Director | 99.2% | Passed | |
| Election of Eric M. Green | Director | 96.8% | Passed | |
| Election of Douglas A. Michels | Director | 96.1% | Passed | |
| Election of Thomas W. Hofmann | Director | 95.3% | Passed | |
| Election of Deborah L. V. Keller | Director | 94.8% | Passed | |
| Election of Mark A. Buthman | Director | 94.3% | Passed | |
| Election of William F. Feehery | Director | 74.4% | Passed |
2021
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote | Company proposal | 95.1% | Passed | |
| Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2021 fiscal year by the following vote | Auditor | 96.1% | Passed | |
| Election of Myla P. Lai-Goldman | Director | 99.4% | Passed | |
| Election of Deborah L. V. Keller | Director | 99.4% | Passed | |
| Election of Robert F. Friel | Director | 99.4% | Passed | |
| Election of Eric M. Green | Director | 99% | Passed | |
| Election of Paolo Pucci | Director | 98.5% | Passed | |
| Election of Mark A. Buthman | Director | 97.5% | Passed | |
| Election of Douglas A. Michels | Director | 97.4% | Passed | |
| Election of Thomas W. Hofmann | Director | 96.6% | Passed | |
| Election of Patrick J. Zenner | Director | 95.6% | Passed | |
| Election of William F. Feehery | Director | 90.1% | Passed |
2020
Proxy statements and vote results
Straight from West Pharmaceutical Services’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.
| Year | Filing | Filed |
|---|---|---|
| 2026 | Vote results | 2026-05-05 |
| 2026 | Proxy statement | 2026-03-12 |
| 2025 | Vote results | 2025-05-08 |
| 2025 | Proxy statement | 2025-03-21 |
| 2024 | Vote results | 2024-04-26 |
| 2024 | Proxy statement | 2024-03-13 |
| 2023 | Vote results | 2023-04-28 |
| 2023 | Proxy statement | 2023-03-15 |
| 2022 | Vote results | 2022-05-26 |
| 2022 | Proxy statement | 2022-04-14 |
| 2021 | Vote results | 2021-05-06 |
| 2021 | Proxy statement | 2021-03-24 |
| 2020 | Vote results | 2020-05-07 |
| 2020 | Proxy statement | 2020-03-25 |
| 2019 | Proxy statement | 2019-03-22 |
| 2018 | Proxy statement | 2018-03-21 |
Do you represent West Pharmaceutical Services? Claim this profile to respond to the campaigns listed here.